Aria Shokoohi
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 25, 2023
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.Marie-Hélène Denault, Jamie Feng, Shelley Kuang
|Jun 27, 2023
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy.Rebekah Rittberg, Bonnie Leung, Aria Shokoohi
|Nov 24, 2022
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.Lauren Jones, Rebekah Rittberg, Bonnie Leung
|Nov 17, 2021
Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world.Aria Shokoohi, Zamzam Al-Hashami, Sara Moore
|Jan 25, 2021
Readiness of Healthcare Systems to Generate Real-World Evidence: Reliability of CT Radiographic End Points for Evaluation of First-Line Systemic Treatment.Cheryl Ho, Brandon Chan, David Cameron
|Jul 30, 2019
Psychosocial Distress Scores and Needs among Newly Diagnosed Sarcoma Patients: A Provincial Experience.Amirrtha Srikanthan, Bonnie Leung, Aria Shokoohi
Pageof 1
Frequent Collaborators
4 joint publications
Cheryl Ho
3 joint publications
Bonnie Leung
2 joint publications
Rebekah Rittberg
2 joint publications
Selina Wong
1 joint publications
Amirrtha Srikanthan
1 joint publications
Alannah Smrke
1 joint publications
David Cameron
1 joint publications
Dean A Regier
1 joint publications
Howard Lim
1 joint publications
Alexandra Pender
